Stocks and Investing Stocks and Investing
Mon, September 16, 2024

Etzer Darout Reiterated (ACRV) at Buy with Increased Target to $28 on, Sep 16th, 2024


Published on 2024-10-28 14:16:21 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of BMO Capital, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy with Increased Target from $25 to $28 on, Sep 16th, 2024.

Etzer, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources